LSPedia 的全球序列化系列
序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.png)
欢迎来到 LspEdia,在这里,创新与奉献精神相结合。
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。

序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。
在充满活力的中国制药行业中,遵守可追溯性要求不仅仅是监管要求;这是对最高安全性和真实性标准的承诺。受中国食品药品监督管理局(CFDA)管辖,《中国药品电子监控工作计划》和《2019年药品管理法》药品追溯要求经过精心设计,以确保药品在整个供应链中的完整性。
每种药品都必须带有唯一的标识符和序列号,便于精确跟踪和追踪。这种数字足迹确保了药品在整个生命周期中的真实性和来源。
公司有义务在供应链的各个阶段提交详细数据,包括生产、分销和销售。这种以数据为中心的方法使监管机构能够有效监控药品流动,并迅速应对任何违规行为。
实施严格的合规监督,包括定期检查和审计,以评估和确保遵守可追溯性法规。违规行为可能导致严重后果,这突显了积极的合规措施的重要性。
中国的可追溯性要求与国际标准保持一致,促进了互操作性,促进了药品的无缝全球贸易。
Our team of compliance experts possesses in-depth knowledge of iTS and Turkish pharmaceutical regulations. From serialization strategies to data reporting, we guide your organization through the intricacies of compliance, ensuring a smooth and informed journey.
Leverage our state-of-the-art compliance solution, designed to integrate seamlessly with iTS requirements. Our technology ensures accuracy, efficiency, and real-time visibility, empowering your organization to meet and exceed compliance expectations.
Compliance is not just about meeting today's standards; it's about preparing for the future. Our solution is designed to evolve with regulatory changes, ensuring that your organization remains at the forefront of compliance in the dynamic Turkish pharmaceutical landscape.
We believe in transparent collaboration. Partner with us, and we'll work closely with your team to implement and maintain compliance measures. Our goal is to build a resilient, compliant, and future-ready pharmaceutical supply chain together.
对于进入中国市场的制药实体来说,接受这些可追溯性要求不仅是监管的必要条件,也是战略上的当务之急。我们的尖端解决方案使您的组织能够无缝地应对这些要求,从而确保合规性、透明度和中国最高的药品安全标准。提升您的运营——选择合规性,选择卓越。
We invite you to learn more about how LSPedia can support your compliance and supply chain needs. For more information about our solutions, partnership opportunities, or to speak with one of our experts.
Stay connected with us on social media and subscribe to our newsletter to receive the latest updates, insights, and innovations from LSPedia.